-
1
-
-
17944374924
-
-
European Society of Cardiology
-
Task Force for the Diagnosis and Treatment of Chronic Heart Failure. European Society of Cardiology. Eur Heart J 2001; 22: 1527-60
-
(2001)
Eur Heart J
, vol.22
, pp. 1527-1560
-
-
-
2
-
-
0036290085
-
Hospitalization of patients with heart failure: A population-based study
-
Cowie MR, Fox KF, Wood DAC, et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J 2002; 23: 877-85
-
(2002)
Eur Heart J
, vol.23
, pp. 877-885
-
-
Cowie, M.R.1
Fox, K.F.2
Dac, W.3
-
3
-
-
0028951035
-
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta adrenergic blockade
-
Hall SA, Cigarroa CG, Marcoux L, et al. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta adrenergic blockade. J Am Coll Cardiol 1995; 25: 1154-61
-
(1995)
J Am Coll Cardiol
, vol.25
, pp. 1154-1161
-
-
Hall, S.A.1
Cigarroa, C.G.2
Marcoux, L.3
-
4
-
-
0030094440
-
Medium-term effects of beta-blockade on left ventricular mechanics: A double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction
-
Rousseau MF, Chapelle F, Van Eyll C, et al. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction. J Card Fail 1996; 2 (1): 15-23
-
(1996)
J Card Fail
, vol.2
, Issue.1
, pp. 15-23
-
-
Rousseau, M.F.1
Chapelle, F.2
Van Eyll, C.3
-
5
-
-
0033514046
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomised trial
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial. Lancet 1999; 353: 9-13
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
-
6
-
-
0034104565
-
Effects of controlled-release metoprolol on total mortality hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF)
-
MERIT-HF Study Group
-
Effects of controlled-release metoprolol on total mortality hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000; 283: 1295-302
-
(2000)
JAMA
, vol.283
, pp. 1295-1302
-
-
-
7
-
-
0034837574
-
Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure
-
Shibata MC, Flather MD, Wang D. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 2001; 3: 351-7
-
(2001)
Eur J Heart Fail
, vol.3
, pp. 351-357
-
-
Shibata, M.C.1
Flather, M.D.2
Wang, D.3
-
8
-
-
0033006276
-
Incidence and aetiology of heart failure; a population-based study
-
Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 1999; 20 (6): 421-8
-
(1999)
Eur Heart J
, vol.20
, Issue.6
, pp. 421-428
-
-
Cowie, M.R.1
Wood, D.A.2
Coats, A.J.3
-
9
-
-
0021881487
-
The effect of age on beta-adrenergic function in man: A review
-
Ebstein RP, Stessman J, Eliakim R, et al. The effect of age on beta-adrenergic function in man: a review. Isr J Med Sci 1985; 21 (3): 302-11
-
(1985)
Isr J Med Sci
, vol.21
, Issue.3
, pp. 302-311
-
-
Ebstein, R.P.1
Stessman, J.2
Eliakim, R.3
-
10
-
-
0035978763
-
Effect of carvedilol on survival in severe chronic heart failure
-
Carvedilol Prospective Randomized Cumulative Survival Study Group
-
Packer M, Coats AJ, Fowler MB, et al., Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-8
-
(2001)
N Engl J Med
, vol.344
, pp. 1651-1658
-
-
Packer, M.1
Coats, A.J.2
Fowler, M.B.3
-
11
-
-
0025279763
-
Xamoterol in severe heart failure
-
published erratum appears in Lancet 1990; 336: 698
-
The Xamoterol in Severe Heart Failure Study Group. Xamoterol in severe heart failure [published erratum appears in Lancet 1990; 336: 698]. Lancet 1990; 336: 1-6
-
(1990)
Lancet
, vol.336
, pp. 1-6
-
-
-
13
-
-
3242889817
-
Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure
-
MERIT-HF Study Group published erratum appears in Eur Heart J 2004; 25: 1968
-
Deedwania PC, Gottlieb S, Ghali JK, et al., MERIT-HF Study Group. Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure [published erratum appears in Eur Heart J 2004; 25: 1968]. Eur Heart J 2004; 25: 1300-9
-
(2004)
Eur Heart J
, vol.25
, pp. 1300-1309
-
-
Deedwania, P.C.1
Gottlieb, S.2
Ghali, J.K.3
-
14
-
-
7644236685
-
The effect of age upon care and outcomes in patients hospitalized for congestive heart failure in Alberta, Canada
-
Cujec B, Quan H, Jin Y, et al. The effect of age upon care and outcomes in patients hospitalized for congestive heart failure in Alberta, Canada. Can J Aging 2004; 23: 255-67
-
(2004)
Can J Aging
, vol.23
, pp. 255-267
-
-
Cujec, B.1
Quan, H.2
Jin, Y.3
-
15
-
-
25444506045
-
Adherence to guidelines is a predictor of outcome in chronic heart failure: The MAHLER survey
-
Komajda M, Lapuerta P, Hermans N, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 2005; 26: 1653-9
-
(2005)
Eur Heart J
, vol.26
, pp. 1653-1659
-
-
Komajda, M.1
Lapuerta, P.2
Hermans, N.3
-
17
-
-
0029937949
-
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
-
US Carvedilol Heart Failure Study Group
-
Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-55
-
(1996)
N Engl J Med
, vol.334
, pp. 1349-1355
-
-
Packer, M.1
Bristow, M.R.2
Cohn, J.N.3
-
18
-
-
3142776467
-
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): Randomised controlled trial
-
Carvedilol or Metoprolol European Trial Investigators
-
Poole-Wilson PA, Swedberg K, Cleland JG, et al., Carvedilol or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003; 362: 7-13
-
(2003)
Lancet
, vol.362
, pp. 7-13
-
-
Poole-Wilson, P.A.1
Swedberg, K.2
Cleland, J.G.3
-
19
-
-
0037159310
-
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study
-
Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group
-
Packer M, Fowler MB, Roecker EB, et al., Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002; 106: 2194-9
-
(2002)
Circulation
, vol.106
, pp. 2194-2199
-
-
Packer, M.1
Fowler, M.B.2
Roecker, E.B.3
-
20
-
-
0033989292
-
Interaction of the beta adrenergic receptor antagonist bucindolol with serotonergic receptors
-
Watts SW, Fink GD, Silver PJ, et al. Interaction of the beta adrenergic receptor antagonist bucindolol with serotonergic receptors. J Cardiovasc Pharmacol 2000; 35: 29-36
-
(2000)
J Cardiovasc Pharmacol
, vol.35
, pp. 29-36
-
-
Watts, S.W.1
Fink, G.D.2
Silver, P.J.3
-
21
-
-
0035978801
-
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
-
Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. New Engl J Med 2001; 344: 1659-67
-
(2001)
New Engl J Med
, vol.344
, pp. 1659-1667
-
-
-
22
-
-
0037904408
-
Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: A novel mechanism for antihypertensive action
-
Kalinowski L, Dobrucki LW, Szczepanska-Konkel M, et al. Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action. Circulation 2003; 107: 2747-52
-
(2003)
Circulation
, vol.107
, pp. 2747-2752
-
-
Kalinowski, L.1
Dobrucki, L.W.2
Szczepanska-Konkel, M.3
-
23
-
-
0036829197
-
Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisations in Seniors with Heart Failure (SENIORS): Rationale and design
-
Shibata MC, Flather MD, Böhm M, et al. Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisations in Seniors with Heart Failure (SENIORS): rationale and design. Int J Cardiol 2002; 86: 77-85
-
(2002)
Int J Cardiol
, vol.86
, pp. 77-85
-
-
Shibata, M.C.1
Flather, M.D.2
Böhm, M.3
-
24
-
-
13544258730
-
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
-
SENIORS Investigators
-
Flather MD, Shibata MC, Coats AJ, et al., SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26: 215-25
-
(2005)
Eur Heart J
, vol.26
, pp. 215-225
-
-
Flather, M.D.1
Shibata, M.C.2
Coats, A.J.3
|